Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Seres Therapeutics, Inc. Announces Closing of Public Offerings of 12,075,000 Shares of Common Stock
-
Seres Therapeutics (MCRB) Prices 10.5M Share Common Offering at $21.50/Sh
-
Seres Therapeutics, Inc. Announces Pricing of Public Offering of 10,500,000 Shares of Common Stock
-
Seres Therapeutics (MCRB) to Offer 8M Common Shares
-
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
-
Seres Therapeutics (MCRB) PT Raised to $14 at Cowen, Following Drug Trial Results
-
Seres Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Highlights
-
Seres Therapeutics to Present at the Cowen 2020 Health Care Conference
-
Seres Therapeutics (MCRB) Prices 26.667M Share Common Offering at $2.25/Sh
-
Seres Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
-
Seres Therapeutics (MCRB) to Offer Common Stock
-
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
-
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
-
Seres Therapeutics to Present at Three Upcoming March Conferences
-
Seres Therapeutics to Present at Two Upcoming March Conferences
-
Seres Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference
-
Cowen Starts Seres Therapeutics (MCRB) at Outperform
-
Seres Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
-
Trading Radar for 2/25: Baidu (BIDU), Best Buy (BBY), Sears (SHLD), Weight Watchers (WTW) Report

